HarbourVest Partners L.P. 13D and 13G filings for Evelo Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-14 06:10 am Unchanged | 2022-12-31 | 13G | Evelo Biosciences, Inc. EVLO | HarbourVest Partners L.P. | 153,175 2.800% | 0 (Unchanged) | Filing |
2021-02-16 07:59 am Purchase | 2020-12-31 | 13G | Evelo Biosciences, Inc. EVLO | HarbourVest Partners L.P. | 153,175 6.600% | 65,000 (+73.72%) | Filing |